CEN Biotech Appoints John A. Germinario as Chairman of the Board
April 17 2014 - 9:00AM
Marketwired
CEN Biotech Appoints John A. Germinario as Chairman of the Board
Respected Industry Veteran to Join Executive Leadership Team;
Bringing Over 33 years of Experience in Global Capital Markets
MADISON HEIGHTS, MI--(Marketwired - Apr 17, 2014) - Creative
Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), CEN
Biotech, announced today the appointment of John A. Germinario as
Chairman of the Board of Directors effective immediately.
As a seasoned banker with over 33 years of experience in global
capital markets, Mr. Germinario will be managing a variety of
immediate tasks including regulatory compliance, risk management,
corporate governance, potential mergers and acquisitions, assessing
market strategy and spearheading financing activities.
"Our association with Mr. Germinario marks the first step in our
relationship with Push Point Management Group and we are extremely
pleased to have John as our Chairman. Our Board of Directors
unanimously voted for his appointment given his expertise,
leadership and results-driven track record," commented Bill
Chaaban, President & CEO. "His corporate ethics and
entrepreneurial skills are valuable in establishing our long term
vision and we are confident that his contributions will further
enhance our shareholder value."
Mr. Germinario currently serves as CEO of Global Securities
Services Corporation an international strategic institution focused
on designing and implementing Depositary Receipt Programs for
publicly traded companies. Prior to joining CEN Biotech, Mr.
Germinario was a global capital markets securities fraud examiner
and worked with the U.S. Securities and Exchange Commission (SEC)
and the Internal Revenue Service (IRS) Whistleblower to identify
multiple levels of securities, bank and tax fraud, resulting in the
collection of hundreds of millions of dollars in unpaid taxes by
four major New York banks. Mr. Germinario continues to work with
the SEC, Federal Bureau of Investigation (FBI) and the IRS on
criminal investigations in an effort to provide a safe and secure
share ownership experience for investors and shareholders.
About CEN Biotech CEN Biotech, Inc. was established in 2013 as a
partially owned subsidiary of Creative Edge Nutrition (OTC Pink:
FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the
Canadian public with pharmaceutical-grade medical cannabis under
the newly established Marihuana for Medical Purposes Regulations
(MMPR). CEN Biotech Inc. has submitted a comprehensive application
to become a licensed producer (LP) of dried marihuana for medicinal
purposes and has received a ready-to-build approval from Health
Canada. http://www.cenbiotechinc.com
About Creative Edge Nutrition, Inc. Creative Edge Nutrition is a
holding company and a Nutritional Supplement Company focused on
developing innovative, high quality supplements. The company offers
a broad spectrum of capsules, tablets, and powders, as well as
science based products in the principal categories of weight
management, nutrition challenges, energy and fitness. The Company
manufactures under strict GMP guidelines at GMP Certified and/or
FDA registered facilities. http://www.cenergynutrition.com and
https://www.facebook.com/CenergyNutrition
About RXNB, Inc. RXNB possesses proprietary, cutting-edge
systems in the field of agriculture, applicable to medical
marijuana. In particular, these technologies focus on Current Good
Manufacturing Practices (cGMP) manufacturing and growing process of
medicinal marijuana. cGMP refers to the Current Good Manufacturing
Practice regulations enforced by the US Food and Drug
Administration (FDA). cGMPs provide for systems that assure proper
design, monitoring, and control of manufacturing processes and
facilities, which assures the identity, strength, quality, and
purity of drug products. RXNB technologies will accelerate plant
growth, allow perpetual grow cycles of about 35 days and protect
plants from adulterants, which will yield greater harvests. RXNB
has a pharmacy division, which dispenses prescription drugs direct
to approximately 50,000 patients per month in the US. RXNB owns a
distribution network, which supplies approximately 2,700 clinicians
with tailored functional medicine across the US. It operates its
own call center and owns software technologies in the field of
tailored specialty drugs and batch record keeping in compliance
with USP 797.
Contact: FOR INVESTOR RELATIONS William Swalm (212) 584-4342
Info@cenergynutrition.com
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Apr 2023 to Apr 2024